Anti-Brexit protesters demonstrate outside the Houses of Parliament, ahead of a vote on Prime Minister Theresa May's Brexit deal, in London, Britain, January 15, 2019. REUTERS/Henry Nicholls
FRANKFURT/DUBLIN (Reuters) - Germany's drug safety regulator has concluded that Brexit will not put its patients at risk of losing access to essential drugs while Ireland has drawn up a watch list of some 24 medicines whose supply would be most vulnerable if Britain crashes out without a divorce deal.
Between 60 and 70 percent of medicines on the Irish market either come from, or transit through the United Kingdom and Irish Prime Minister Leo Varadkar said a working group of health officials has been meeting weekly for the last two years to examine any potential supply disruptions.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
